Aberrant Bcl6 protein expression in mantle cell lymphoma

American Journal of Surgical Pathology

Volumn 28, Issue 8, 2004, Pages 1051-1056

  Camacho, Francisca I ^a   Garcia, Juan F ^a   Cigudosa, Juan C ^a   Mollejo, Manuela ^b   Algara, Patrocinio ^b   Ruiz Ballesteros, Elena ^b   Gonzalvo, Pablo ^c   Martín, Paloma ^d   Pérez Seoane, Carlos ^e   Sánchez García, Joaquín ^e   Piris, Miguel A ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b HOSPITAL VIRGEN DE LA SALUD   (Spain)

^c Hospital de Jarrio   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

^e HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

3q27; Bcl6; Mantle cell lymphoma

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; PROTEIN BCL 6;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BCL6 GENE; CANCER DIAGNOSIS; CELL PROLIFERATION; CHROMOSOME 3Q; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 3; CLINICAL ARTICLE; CLUSTER ANALYSIS; FEMALE; GENE; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IGVH GENE; IMMUNOGLOBULIN GENE; LYMPHOMA; MALE; MANTLE CELL LYMPHOMA; MUTATIONAL ANALYSIS; MUTATIONAL INDEX; PROLIFERATION INDEX; PROTEIN EXPRESSION; SCORING SYSTEM;

AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 3; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 3242769765     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000128671.92609.af     Document Type: Article

References (27)

1. Algara P, Mateo MS, Sanchez-Beato M, et al. Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course. Blood. 2002:99:1299-1304.
2. Artiga M.I. Saez AI, Romero C, et al. A short mutational hot spot in the first intron of BCL-6 is associated with increased BCL-6 expression and with longer overall survival in large B-cell lymphomas. Am J Pathol. 2002;160:1371-1380.
3. Bastard C, Deweindt C, Kerckaert JP, et al. LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood. 1994:83:2423-2427.
4. Camacho FI, Algara P, Rodriguez A, et al. Molecular heterogencity in MCL defined by the use of specific VH genes and the frequency of somatic mutations. Blood. 2003;101:4042-4046.
5. Capello D, Vitolo U, Pasqualucci L, et al. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood. 2000;95:651-659.
6. Chen W, Iida S, Louie DC, et al. Heterologous promoters fused to BCL6 by chromosomal translocations affecting band 3q27 cause its deregulated expression during B-cell differentiation. Blood. 1998:91:603-607.
7. Dong HY, Gorezyca W, Liu Z, et al. B-cell lymphomas with coexpression of CD5 and CD 10. Am J Clin Pathol. 2003:119:218-230.
8. Frater JL, Tsiftsakis EK, Hsi ED, et al. Use of novel t(11:14) and t(14:18) dual-fusion fluorescence in situ hybridization probes in the differential diagnosis of lymphomas of small lymphocytes. Diagn Mol Pathol. 2001: 10:214-222.
9. Gaidano G, Carbone A, Pastore C, et al. Frequent mutation of the 5′ noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas. Blood. 1997:89:3755-3762.
10. Jaffe ES, Stein H, and Vardiman JW. Pathology and Genetics of Tumours of Haematopoietic and lymphoid Tissues: Health Organization Classification of Tumours. Lyon, France: IARC Press: 2001.
11. Kuppers R, Zhao M, Hansmann ML, et al. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J. 1993;12:4955-4967.
12. Liu Z, Dong HY, Gorezyca W, et al. CD5-mantle cell lymphoma. Am J Clin Pathol. 2002;118:216-224.
13. Lo Coco F, Ye BH, Lista F, et al. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood. 1994;83:1757-1759.
14. Lossos IS, Levy R. Mutation analysis of the 5′ noncoding regulatory region of the BCL-6 gene in non-Hodgkin lymphoma: evidence for recurrent mutations and intraclonal heterogeneity. Blood. 2000;95:1400-1405.
15. Mateo MS, Mollejo M, Villuendas R, et al. Molecular heterogeneity of splenic marginal zone lymphomas: analysis of mutations in the 5′ noncoding region of the bcl-6 gene. Leukemia. 2001;15:628-634.
16. Migliazza A, Martinotti S, Chen W, et al. Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proc Nat. Acad Sci USA. 1995;92:12520-12524.
17. Miura I, Ohshima A, Chubachi A, et al. BCL6 rearrangement in a patient with mantle cell lymphoma. Ann Hematol. 1997:74:247-250.
18. Otsuki T, Yano T, Clark HM, et al. Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequences. Blood. 1995;85:2877-2884.
19. Pasqualucci L, Migliazza A, Fracchiolla N, et al. BCL-6 mutations in nonnal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci USA. 1998;95:11816-11821.
20. Peng HZ, Du MQ, Koulis A, et al. Nonimmunoglobulin gene hypermutation in germinal center B cells. Blood. 1999;93:2167-2172.
21. Pezzella F, Ralfkiaer E, Gatter KC, et al. The 14:18 translocation in European cases of follicular lymphoma: comparison of Southern blotting and the polymerase chain reaction. Br J Haematol. 1990;76:58-64.
22. Quintanilla-Martinez L, Thieblemont C, Fend F, et al. Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor. Am J Pathol. 1998:153:175-182.
23. Raty R, Franssila K, Joensuu H, et al. Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma. Eur J Haematol. 2002;69:11-20.
24. Sanchez-Beato M, Sanchez-Aguilera A, Piris MA. Cell cycle deregulation in B-cell lymphomas. Blood. 2003:101:1220-1235.
25. Shen M, Peters A, Baron B, et al. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science. 1998: 280:1750-1752.
26. Thorselius M, Walsh S, Eriksson I, et al. Somatic hypermutation and V(H) gene usage in mantle cell lymphoma. Eur J Haematol. 2002;68:217-224.
27. Ye BH, Chaganti S, Chang CC, et al. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. EMBO J. 1995;14:6209-6217.